1.Aldape, MJ, Bryant, AE, Stevens, DL. Clostridium sordellii infection: epidemiology, clinical findings, and current perspectives on diagnosis and treatment. Clin Infect Dis 2006;43:1436–1446.
2.Popoff, MR. Purification and characterization of Clostridium sordellii lethal toxin and cross-reactivity with Clostridium difficile cytotoxin. Infect Immun 1987;55:35–43.
3.Martinez, RD, Wilkins, TD. Purification and characterization of Clostridium sordellii hemorrhagic toxin and cross-reactivity with Clostridium difficile toxin A (enterotoxin). Infect Immun 1988;56:1215–1221.
4.Hao, Y, Senn, T, Opp, JS, et al.Lethal toxin is a critical determinant of rapid mortality in rodent models of Clostridium sordellii endometritis. Anaerobe 2009 [Epub ahead of print].
5.Menon, A, Stefanova, R, Mwangi, P, Ruhe, J, Hoffman, K, Woods, GL. A pseudo-outbreak of Clostridium sordellii linked to contamination with a laboratory reference strain. Paper presented at: 16th Annual Meeting of the Society for Healthcare Epidemiology of America, March 18-21,2006; Chicago, IL.
6.Lynch, JM, Anderson, A, Camacho, FR, Winters, AK, Hodges, GR, Barnes, WG. Pseudobacteremia caused by Clostridium sordellii. Arch Intern Med 1980;140:65–68.
7.McGregor, JA, Equils, O. Risks of mifepristone abortion in context: author reply. Contraception 2006;74:175–176.
8.McGregor, JA, Soper, DE, Lovell, G, Todd, JK. Maternal deaths associated with Clostridium sordellii infection. Am J Obstet Gynecol 1989;161:987–995.
9.Clabots, CR, Johnson, S, Bettin, KM, et al.Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems. J Clin Microbiol 1993; 31:1870–1875.
10.Klaassen, CH, van Haren, HA, Horrevorts, AM. Molecular fingerprinting of Clostridium difficile isolates: pulsed-field gel electrophoresis versus amplified fragment-length polymorphism. J Clin Microbiol 2002;40:101–104.